Apollo Endosurgery, Inc. to Report Third Quarter 2020 Results on November 5, 2020

Rhea-AI Summary

Apollo Endosurgery, Inc. (NASDAQ:APEN) will release its financial results for Q3 2020 on November 5, 2020, after U.S. market close. A conference call is scheduled for the same day at 3:30 p.m. CT to discuss the results. Participants can join by dialing +1-785-424-1667 or via a live webcast on the company’s investor relations page. Apollo specializes in less invasive medical devices for gastrointestinal and bariatric procedures, with products available in over 75 countries. For further details, visit www.apolloendo.com.

AUSTIN, TX / ACCESSWIRE / October 29, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020, after the U.S. stock markets close.

Apollo will hold a conference call on Thursday, November 5, 2020 at 3:30 p.m. CT / 4:30 p.m. ET to discuss the results. To join the call by telephone, please dial +1-785-424-1667. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.apolloendo.com.

A replay of the webcast will be made available on Apollo's website, www.apolloendo.com, shortly after completion of the call.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contacts

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc.

View source version on accesswire.com:
https://www.accesswire.com/613175/Apollo-Endosurgery-Inc-to-Report-Third-Quarter-2020-Results-on-November-5-2020

FAQ

When will Apollo Endosurgery report its third quarter results for 2020?

Apollo Endosurgery will report its third quarter results on November 5, 2020.

What time is the Apollo Endosurgery conference call?

The conference call will take place at 3:30 p.m. CT on November 5, 2020.

How can I participate in the Apollo Endosurgery conference call?

You can join the call by dialing +1-785-424-1667 or through a live webcast on their investor relations page.

Where can I find Apollo Endosurgery's Q3 2020 financial results after release?

The financial results will be available on Apollo's corporate website shortly after the release.

What does Apollo Endosurgery specialize in?

Apollo Endosurgery specializes in less invasive therapies for gastrointestinal conditions.